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INTRODUCTION 
 
 
 
 
 Carcinoma of periampullary region accounts for 85% of  
pancreaticoduodenectomies at our institute.Tumours of ampulla of vater are 
relatively rare, with an crude incidence rate of 0.53 /1,00,000 population per 
year(1).Overall periampullary cancers account for 5 % of all gastrointestinal  tract 
malignancies(2).A periampullary carcinoma – one arising in the region of ampulla of 
vater , may be from one of four potential origins- pancreas ,bile duct, the ampulla 
itself or periampullary duodenum. Surgical series of periampullary tumors have 
demonstrated that patients with ampullary tumors have a more favourable prognosis 
than those with pancreatic or bile duct tumors(3,4,5,6,) with median survivals of 30 
to 50 months(7,8) and 5-year survival rates between 30% and 50%(9,10).Lymph 
node metastasis and vascular invasion were found to be independent factors 
adversely influencing survival in an Indian study(11).Studies attempting to determine 
important factors affecting survival have been limited by several factors..Most 
contain small numbers of patients collected over many decades & many do not use 
multivariate analysis to identify independent  prognostic factors.Furthermore , most 
studies do not assess preoperative factors such as age or biochemical variables. 
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REVIEW OF LITERATURE 
 
 
 
ANATOMY: 
 
 
 Although the ampulla of vater is anatomically a small structure ,it and the 
surrounding periampullary duodenum give rise to a surprising number & variety of 
neoplasms that often present with dramatic symptoms because of the strategic 
location of the ampulla at the confluence of the pancreatic and biliary ducts.The 
ampulla itself includes several different epithelia : the duodenal mucosa covering the 
papilla,pancreatic ductal epithelium and that of the distal common bile duct,and the 
epithelium lining the common channel – the short union of the two ducts within the 
duodenal wall.The epithelium lining the ducts and the common channel is 
histologically similar (pancreatobiliary-type epithelium),whereas the papilla is 
covered by intestinal – type epithelium. 
 
RISK FACTORS 
 
 Patients with Familial Adenomatous Polyposis have a markedly higher 
frequency of ampullary adenocarcinoma ranging from 50 - 86%(12,13) 
.Histologically proven adenomas of papilla are premalignant & follow the adenoma - 
carcinoma sequence similar to that seen in the colon(14). 
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PATHOLOGY: 
 
 Periampullary tumours originate from the head of pancreas,ampulla of 
vater,distal common bile duct and the duodenum.They constitute 30 % of malignant 
tumours that arise from the pancreatic head region..Periampullary tumours  display 
unique characteristics due to their specific origin. 
 
 These tumours are derived either from the epithelium,connective 
tissue,lymphoid tissue or the neuroendocrine cells.Tumours derived from the 
epithelium are common as compared to those derived from other parts.WHO has not 
classified periampullary tumours separately but have included them in the 
classification of tumours of small intestine.The following is the WHO classification 
of tumours in the periampullary region. 
 
1. Epithelial tumours  
• Benign – adenoma 
• Premalignant lesions –dysplasia 
• Malignant – adenocarcinoma 
2. Neuroendocrine tumours-carcinoids, gangliocytic paraganglioma 
3. Stromal tumours – Gastrointestinal Stromal Tumour 
• Lipoma 
• Kaposi s sarcoma 
• Others  
4. Malignant lymphomas 
5. Secondary tumours 
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6. Hyperplastic polyps, 
• Adenomatous hyperplasia,pancreatic heterotopia. 
 
Carcinoma of the periampullary region: 
 
 Periampullary carcinomas are 2 to 3 cm in diameter and are divided into 3 
forms;intramural protruding ,exposed protruding and ulcerating form. 
 
CLINICAL FEATURES: 
 
 The hallmark clinical presentation for periampullary cancer is 
jaundice,resulting from obstruction of the intrapancreatic portion  of the common 
bile duct. The obstructive jaundice,  fluctuates, when the tumor sloughs off .The 
jaundice is associated with dark urine,light stool, and pruritis.Nonspecific symptoms 
such as nausea, anorexia ,weight loss,and fatique are common in many patients with 
periampullary cancer. . Some may complain of pain in the upper abdomen, 
emaciation, dark stools, anemia and upper gastrointestinal obstruction. On initial 
presentation, jaundice is the most common physical finding.Evidence of cutaneous 
scratching is commonly present,secondary to pruritis.Abdominal examination reveals 
hepatomegaly with palpable gall bladder. 
 
 Pruritus is a well-recognized manifestation among patients with liver diseases 
and intrahepatic or posthepatic cholestasis.  The pruritus is generalized and more 
intense on hands, feet and around tight-fitting clothes, while face, neck and genital 
area are rarely involved . The pathogenesis is still poorly understood, as the precise 
substance  responsible for it is not known. Some authors believe it is caused by the 
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bile acids in the blood (cholemia) or skin , but there is a poor correlation between the 
skin concentration of bile salts and intensity of pruritus. Recently, an elevation of 
endogenous opioids was found in the blood of these patients , and treatment with the 
opiate antagonist naloxone improved pruritus. The itch in patients with cholemic 
pruritus can be lessened by treatment with cholestyramine, phototherapy, 
plasmapheresis which lower or remove the unknown circulating pruritogen; 
antihistamines can be used as adjuvants. Ursodeoxycholic acid has been used (10-15 
mg/kg) with good success. Interestingly, some serotonin subtype-3-receptor 
antagonists like ondansetron, given intravenously, have been helpful in the treatment 
of cholestatic pruritus. 
 
INVESTIGATIONS: 
 
 Laboratory analysis often reveals elevated liver function studies,reflecting the 
degree of biliary obstruction . In deeply jaundiced patients with malabsorption of fat 
soluble vitamins ,prolongation of the prothrombin time may be seen. 
 
 US, CT and MRCP are widely used because of their availability and non-
invasiveness. The role of these techniques in the diagnosis of ampullary carcinoma will 
continue to evolve with experience accumulated. 
 
ULTRASONOGRAPHY:  
 
 Ampullary carcinoma presents two signs on US,(15) direct sign: a lump echo 
in the ampullary region of the common bile duct, and indirect sign: distention of 
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intrahepatic and extrahepatic ducts and distention of the duct of Wirsung. These signs 
are accompanied with gallbladder enlargement, muddy stones, and common duct 
stones. Although US is noninvasive, intestinal gas and costa influence the images of 
the tumor at the distal end of the common bile duct and the papillary region. 
Experienced ultrasound specialists judge the tumor by the images of echo calcification 
and fibrosis, or on the basis of dilatation of intrahepatic and extrahepatic bile ducts. 
Clinically, the incidence of common duct stones is higher than that of ampullary 
carcinoma, so ampullary carcinoma is often misdiagnosed as common duct stone when 
strong echoes are found to be accompanied with a sound shadow in the common bile 
duct. Because of the obscure localization of the lesion, it is difficult to distinguish 
ampullary carcinoma from periampullary carcinoma including carcinoma of the 
pancreatic head and carcinoma of the lower segment of the common bile duct by US. 
Thus US should be used as a method for initial screening of ampullary carcinoma.(16) 
 
CT ABDOMEN & PELVIS: 
 
 CT is commonly used clinically and has a higher accuracy in detecting diseases 
of the abdominal cavity. It is difficult to distinguish ampullary carcinoma from 
periampullary carcinomas such as carcinoma of pancreatic head and 
cholangiocarcinoma in the lower common bile duct.(17). The diagnosis of ampullary 
carcinoma by CT is dependent on a soft-tissue mass of Vater's ampulla and the local 
irregular filling defect of the descending duodenum. The double duct dilatation sign 
(dilatation of the whole segment of common bile duct, dilatation of pancreatic duct), 
gallbladder enlargement and dilatation of intrahepatic and extrahepatic bile ducts are 
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indirect signs of this disease (18, 19). It is highly suspected when CT presents the 
thickening wall of the descending duodenum and its accretion with the head of the 
pancreas. Pancreatic cancer characterized by hypovascularity is seen on enhanced CT 
as a low-density mass in the uncinate process and the head of the pancreas. It grows 
around the lumen, and infiltrates into the blood vessels, bile duct and pancreatic duct 
easily. When the pancreatic cancer infiltrates into the pancreatic duct and common bile 
duct, it causes stenosis and dilatation of the pancreatic duct and the common bile duct. 
Enhanced CT can effectively detect pancreatic carcinoma with the acquisition of two 
sets of images after infusion of contrast material. The first phase after infusion takes 
place during the arterial enhancement. It is useful to detect tumor vascular encasement 
and the maximum difference of tissue attenuation between normal greater pancreatic 
enhancement and hypodense pancreatic mass. The peak parenchymal enhancement 
shown by helical CT may improve the sensitivity of CT in detecting small tumors 
confined within the pancreas. The second phase takes place during the venous or portal 
enhancement to provide useful information about venous encasement and hepatic 
metastasis. Extraglandular extension appears as soft-tissue attenuation thickening 
obscuring the perivascular fat with deformity, thrombosis or occlusion of the vessels. 
In cases of venous occlusion, collateral vein and dilatation of small veins around the 
head of the pancreas can be identified (20). 
 
 Cholangiocarcinoma is a malignant tumor arising from the epithelia of the bile 
duct, and mainly occurs in the hepatic hilum clinically. In early stage, the tumor 
infiltrates into the wall of the bile duct, leading to irregular stenosis of the lumen.  
Cholangiocarcinoma in the lower common bile duct is relatively rare, but it is similar 
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to ampullary carcinoma and differential diagnosis is necessary. Enhanced CT shows 
the shadow of irregular stenosis in the pancreatic segment of the common bile duct, 
papillary tubercles which intrude the lumen and the upper common bile duct dilatation 
without the pancreatic duct dilatation, which are helpful to distinguish between 
cholangiocarcinoma and ampullary carcinoma.(21,22,23). CT also shows the 
localization and extension of the carcinoma, and the presence or absence of remote 
metastasis.(24) Moreover, the thin-section multidetector CT can effectively distinguish 
ampullary carcinoma from benign papillary stricture(25).  
 
. Conventional ultrasonography is an easy and safe examination, does not 
entail radiation exposure ,and is relatively inexpensive.Both CT and Ultrasound 
confirm the obstructive nature of jaundice by demonstrating dilated intrahepatic & 
extrahepatic biliary radicals.Morrin et al studied 23 patients with periampullary 
cancer using both multiphase helical CT and ultrasonography with Doppler and 
found close congruence both in the ability of two studies to  predict vascular 
involvement and in their ability to image metastasis.(26)   Currently,multidetector 
computer tomography with three dimensional reconstruction is the preferred imaging 
modality to diagnose and stage periampullary & pancreas.(27) 
 
ERCP & MRCP:  
 
 MRCP is highly accurate in detecting the obstruction and dilatation of the 
biliary system. However, it is difficult to reveal the small mass at the ampulla. MRCP 
can provide intuitive and reliable information about the pancreaticobiliary duct and is 
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thought to replace diagnostic ERCP.(28). But it fails to provide biopsy and is hard to 
identify whether the obstruction is benign or malignant. Thus it is used for auxiliary 
examination before surgical treatment or ERCP. 
 
 As a new method for the diagnosis and treatment of diseases of the pancreatic 
and biliary system, ERCP is highly accurate in detecting malignant biliary obstruction 
diseases including ampullary carcinoma.ERCP delineates pancreatic duct and 
common bile duct anatomy.On ERCP, ampullary carcinoma is shown as an irregularly 
enlarged or cauliflower-like mass, with congestive, erosive and ulcerative surface. On 
the other hand, the filling defects of benign obstruction such as common duct stones 
are regular in ERCP (29). 
 
 Moreover, ERCP can retrieve biopsy specimens and brush cytology samples 
for final pathological diagnosis. A biopsy of periampullary mass showing invasive 
adenocarcinoma will be diagnostic in virtually all cases , however , histologic finding 
of a benign villous adenoma with or without dysplasia can not  reliably rule out 
malignancy.  Some patients may be subjected to interventional therapy including 
biliary drainage, composite stone dislodgment, biliary tract dilation, and resection of 
ampullary tumor under ERCP(30).ERCP should be reserved for patients in need for 
endoscopic stenting,equivocal findings on standard evaluation or for those patients in 
whom tissue diagnosis is needed.several retrospectivestudies have found fewer 
complications with the use of preoperative stents.These groups have found no stent 
related morbidity or an association between stents and woundinfection or wound 
infection and pancreatic fistula during post operative period for 
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pancreaticoduodenectomy.Periampullary cancer can be confirmed by several 
methods preoperatively.  
 
 ERCP thus is required to rule out the duodenal papillary lesion when the 
patient is diagnosed with dilatation of the intrahepatic and extrahepatic bile ducts but 
without a clear obstruction on US or CT. The detectability of ampullary carcinoma by 
ERCP is superior to that of US or CT, i.e., a diagnostic accuracy for 95%.(31).  
 
 ERCP has its shortcomings. First, its invasiveness produces more 
complications than other examinations. Second, it cannot detect the infiltration into the 
surrounding lymph tissue or other organs. Thus it fails to distinguish the stage of the 
tumor. The ability of Magnetic resonance imaging (MRI) to diagnose and stage 
periampullary and pancreatic cancer has improved as a result of advances   in image 
resolution acquisition speed ,and Magnetic Resonance cholangiopancreatography 
(MRCP) (32).  Ultrafast spinecho MRI has been reported to be more sensitive than 
classic CT scanning ,but because of motion artifacts ,lack of bowel opacification,low 
spacial resolution, and low signal to noise ratio MRI has not been shown to have 
advantage over modern CT scanning.(33).MRCP holds promise as a noninvasive 
technique to image the biliary and pancreatic ductal systems in a fashion similar to 
ERCP. 
 
DIAGNOSTIC LAPOROSCOPY: 
 
 Laporoscopy has the potential to detect small surface liver and peritoneal 
metastasis.When combined with laporoscopic ultrasound ,laporoscopy may allow 
 11
evaluation of enlarged lymph nodes,vascular involvement, and deep intrahepatic 
metastases from periampullary and pancreatic cancer.With the continued 
improvements in noninvasive imaging modalities, the added value of laporoscopic 
staging has been questioned.(34). 
 
 When ampullary carcinoma is suspected, blood biochemistry tests and US can 
be done, followed by detection of local extension of the carcinoma by CT, MRCP, or 
ERCP. 
 
STAGING: 
 
Over the years, multiple systems for staging this tumor have been proposed. 
• Martin proposed a 4-stage system, as follows:  
o Stage I - Vegetating tumor limited to the epithelium with no involvement of 
the sphincter of Oddi 
o Stage II - Tumor localized in the duodenal submucosa without involvement 
of the duodenal muscularis propria but possible involvement of the sphincter 
of Oddi 
o Stage III - Tumor of the duodenal muscularis propria 
o Stage IV - Tumor of the periduodenal area or pancreas, with proximal or 
distal lymph node involvement 
• The classification system of Yamaguchi and Enjoji is similar to the Martin 
classification. 
• Talbot et al devised a system that scored tumors according to the degree of 
infiltration (from 1-4 according to increasing infiltration) and according to tumor 
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differentiation (from 1-3 for well, moderately, and poorly differentiated tumors), 
the sum of which separated the patients into 2 groups (scores 2-4 and scores 5-7). 
 
 The currently accepted American Joint Committee on Cancer staging system 
for ampullary carcinoma emphasizes the importance of pancreatic invasion and 
lymph node metastases. Size has little impact on tumor stage. The definition of 
primary tumor (T), regional lymph node (N), and remote metastases (M) for 
classification and staging of  cancer of the ampulla of Vater is as follows: (UICC,7th  
EDITION). 
 
Primary tumor  
 
 TX – Primary tumor cannot be assessed 
 T0 – No evidence of primary tumor 
 Tis – Carcinoma in situ 
 T1 – Tumor limited to ampulla of Vater or sphincter of oddi. 
 T2 – Tumor invades duodenal wall 
 T3 – Tumor invades  pancreas 
 T4 – Tumor invades peripancreatic soft tissue or other  adjacent organs or 
structures. 
 
Regional lymph nodes  
 
 NX – Regional lymph nodes cannot be assessed 
 N0 – No regional lymph node metastases 
 N1 – Lymph node metastases 
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Distant metastases  
 
• MX – Presence of distant metastases cannot be assessed 
• M0 – No distant metastases 
• M1 – Distant metastases 
 
Stage grouping of Ampullary Cancers by the TNM System  Table:1 
Stage T N M 
Stage 0 Tis N0 M0 
Stage IA 
Stage IB 
T1 
T2 
N0 
N0 
M0 
M0 
Stage IIA 
Stage IIB 
T3 
T1 
T2 
T3 
N0 
N1 
N1 
N1 
M0 
M0 
M0 
M0 
Stage III T4 anyN M0 
Stage IV anyT AnyN M1 
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PREOPERATIVE BILIARY STENTS: 
 
Table:2 
Morbidity Following Pancreaticoduodenectomy: Association with Preoperative 
Biliary Stents 
Group 
(Reference) Stent N 
Mortality 
(%) 
Overall 
Morbidity 
(%) 
Wound 
Infection 
Other  Stent-
Related 
Complications(%) P 
JHMI (35) Y 408 1.7 35 10.0 .02 Pancreatic 
fistula 
 N 158 2.5 30 4.0   
Univ. 
Amsterdam 
(36) 
Y 232 1.2 50 7.3 NS  
N 58 0.0 55 8.6   
M. D. 
Anderson (37) 
Y 172 0.6 88 13.0 .029  
N 93 1.0 86 4.0   
University of 
Berna (38) 
Y 50 4.0 56 13.0 NS  
N 15 0.0 53 10.0   
SGP Institute 
(39) 
Y 54 15.0 48 43.0 .03 Pancreatic 
fistula 
 N 41 10.0 55 24.0  Overall 
infection 
Hines VA (40) Y 154 2.0 67 8.0 .039  
 N 58 2.0 57 0.0   
JHMI, Johns Hopkins Medical Institutes; SGP: Sanjay Gandhi Postgraduate; VA: 
Veterans Administration;NS,notsignificant 
 
 
 Biliary stents relieve obstruction and are inserted using percutaneous 
transhepatic or endoscopic techniques. Soft silastic stents can be changed 
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periodically, and their use in patients with resectable lesions can maintain a patent 
CBD during neoadjuvant therapy or referral to a regional center with a focus on 
pancreatic cancer. Expandable metal stents do not have the interchangeability of 
silastic stents. These stents are useful for palliation in patients with unresectable 
tumors. If placed in patients with resectable tumors, the most superior extent of the 
stent should be at the confluence of the cystic duct and the common bile duct, 
allowing division of the common bile duct above the cystic duct entrance in any 
subsequent procedure. 
 
 Several retrospective studies have found fewer complications with the use of 
preoperative stents . These groups found no stent-related morbidity or an association 
between stents and wound infection or wound infection and pancreatic fistula during 
the postoperative period for pancreaticoduodenectomy. One of these investigators, 
Pisters et al.(37) at M.D. Anderson Cancer Center (MDACC) comprehensively 
scrutinized 300 consecutive patients treated with pancreaticoduodenectomy, finding 
172 had been decompressed with a prosthetic stent, 35 with operative bypass, and 93 
not drained. Only wound infection was found to be associated with preoperative 
biliary stenting (stent 13% vs. no stent 4%; P = .029). The bacterial species identified 
by intraoperative bile culture and at any subsequent wound infection are frequently 
the same, so the results of an intraoperative bile culture can direct antimicrobial 
choice when a wound infection is initially suspected. 
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 Preoperative endobiliary stenting is a safe intervention that results in 
increased rates of postoperative wound infection, but should not be avoided when 
used to palliate patients for transfer to a high-volume center 
 
OPERATIVE RESECTION: 
HISTORY & EVOLUTION OF PANCREATICODUODENECTOMY: 
 
 The surgical history of the treatment of periampullary tumors encompasses 
the past 100 years. Halsted(41) reported the first successful resection of an ampullary 
tumor in1899, describing a local ampullary resection with associated reanastomosis 
of the pancreatic and bile duct into the duodenum. Codivilla, near the turn of the 
century,performed an en bloc resection of the head of the pancreas and duodenum for 
periampullary carcinoma, but the patient did not survive the postoperative 
period(42). In 1912,Kausch,(43) a German surgeon from Berlin, performed the first 
successful pancreaticoduodenectomy in two stages.  In 1914, Hirsche(44) reported a 
successful one-stage pancreaticoduodenectomy.  Despite these early attempts at 
combined pancreaticoduodenal resection in the early part of the 20th century, up 
until 1935, most ampullary cancers were managed by a transduodenal approach 
similar to that first performed successfully by Halsted. In 1935, a review by Hunt and 
Budd(45) described 76 patients with periampullary tumors managed by such an 
approach, with an operative mortality of 40%.In 1935, Whipple et al.(46) reported 
three patients with ampullary cancer treated by a two-stage 
pancreaticoduodenectomy.In 1937, Brunschwig(47) reported extending the 
indication for pancreaticoduodenectomy to include cancer of the head of the 
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pancreas.  Whipple(46) embarked on perfecting pancreas head resection in 1934, and 
in the subsequent 30 years he and contemporary surgeons of the period revised the 
resection to a technique resembling that used by most surgeons today. Early 
historical procedures utilized a two-stage approach with an initial biliary bypass. 
Patients demonstrated hepatic dysfunction due to biliary obstruction, and the initial 
drainage procedure allowed for normalization of coagulopathy prior to a second 
procedure during which varying amounts of the pancreatic head and duodenum were 
resected. An evolving understanding of the coagulopathy and the addition of vitamin 
K to the preoperative regimen of these patients allowed for single-stage procedures 
to be routinely completed in the 1940s. During the 1940s and 
1950s,pancreaticoduodenectomy was accomplished routinely as a one-stage 
procedure, applied to patients with periampullary neoplasms, and was performed 
with increased frequency.During the 1960s and 1970s, pancreaticoduodenectomy 
was a formidable operation, which carried a hospital mortality that approached 25% 
in some series and led some authors to suggest that its use be abandoned.(48,49) 
There were, however, exceptions to this high mortality rate, notably a report by 
Howard(50) in 1968 describing 41consecutive patients treated by 
pancreaticoduodenectomy without a hospital mortality. In recent years, improved 
hospital morbidity, mortality, and survival after pancreaticoduodenectomy have been 
reported.(4,51-53). 
 
 In recent years, the indications for pancreaticoduodenectomy have expanded, 
concomitant with the declining morbidity and improving patient survival. The 
procedure,whereas applied most commonly with curative intent for periampullary 
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adenocarcinoma, also can be indicated for a variety of other periampullary 
neoplasms(8,54-56) . In addition, a recent report has suggested that 
pancreaticoduodenectomy, when performed with similar perioperative morbidity and 
mortality rates as can be achieved for palliative bypass procedures, may be 
associated with improved long-term survival in patients with locally advanced 
periampullary adenocarcinoma(57).Pancreaticoduodenectomy has been used 
increasingly in recent years as a safe and appropriate resectional option in selected 
patients with malignant and benign disorders of the pancreas and periampullary 
region.The operative mortality rate after pancreaticoduodenectomy is now <4% in 
many high-volume centers.(4,51,58-60).Although a low mortality rate has been 
observed,the incidence of postoperative morbidity can approach 50%. Common 
postoperative complications include delayed gastric emptying, disruption of the 
pancreatic-enteric anastomosis with subsequent pancreatic fistula, wound infection, 
and hemorrhage(54,58-60).Many factors may contribute to the declining mortality 
rate associated with this complex general surgical procedure. There can be no doubt 
that careful patient preoperative assessment, improved surgical technique,and 
improvements in perioperative care (including major improvements in interventional 
radiology and critical care management) all contribute to these declining mortality 
rates. In addition, recently published data from two large state-wide registries have 
shown a relation between hospital volume for a complex surgical procedure such as 
pancreatic resection and perioperative mortality rates. 
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SURGICAL STEPS: 
 
 Evans et al.(61) has described a stepwise methodology that can be applied to 
pancreaticoduodenectomy and is widely applicable to most resections. This can be 
summarized as six steps of resection followed by four steps of reconstruction. 
 
Six surgical steps of pancreaticoduodenectomy (clockwise resection).  
 
1. Cattell – Braasch manuevre exposing superior mesenteric vein. 
2. Extended Kocher’s Maneuvre 
3. Portal dissection  
4. Transect stomach 
5. Transect jejunum and dissect ligament of treitz and rotate jejunum under 
mesenteric vessels. 
6. Transect pancreas and complete retroperitoneal dissection by removing 
specimen from SMA. 
 
Four steps of reconstruction: 
 
1. End to side pancreatico jejunostomy/Pancreaticogastrostomy. 
2. End to side choledochojejunostomy 
3. End to side gatro jejunostomy 
4. Gastrostomy  tubes,jejunostomy tubes,Drains 
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Intraperitoneal Drains: 
 
 Intraperitoneal drains are usually placed intraoperatively in the vicinity of the 
pancreatic and biliary anastomosis following pancreas resection. A single study 
prospectively evaluated the contribution of this drainage to the postoperative course. 
One hundred seventy-nine patients who underwent pancreatic resection 
(pancreaticoduodenectomy: 139, distal pancreatectomy: 40) were randomized to 
have drains (88 patients) or no drains (91 patients) placed at the conclusion of the 
case. Placement of drains did not decrease the need for subsequent percutaneous 
drainage of an intra-abdominal collection (drain: eight patients, no drain: seven 
patients) and the incidence of intraperitoneal sepsis, fluid collection, or fistula was 
increased in the patients who were randomized to intraperitoneal drain (drain: 19 
patients, no drain: eight patients)(62). Inexplicably, drains remain widely used in 
pancreatic resection, and at the least, a duplicate prospective trial is needed from 
another major specialty center to determine whether this practice should be 
continued. 
 
 Surgical resection of periampullary carcinoma  remains the only potentially 
curative theraphy. Compared with classic pancreaticoduodenal resection(which 
includes distal gastrectomy), pylorus preserving pancreatico duodenectomy does not 
seem to be associated with an increase in postoperative complications or other 
adverse  sequelae.(63,64).Equivalent survival and quality of life after both types of 
resection are  available(65,66). Pancreaticogastrostomy is better  at least not worse  
than Pancraticojejunostomy in terms of Complications and Pancreatic leakage.In the 
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John Hopkins randomized prospective study between 1993-1995, 145 patients were 
studied.Pancreatic leak rate was 1.7%.No significant difference between PG and PJ. 
Two small randomized controlled Trials reported a shorter operative time, less blood 
loss,fewer blood transfusions, and a lower morbidity for PPPD(64,67). However, a 
larger multicenter randomized controlled trial did not show significant differences 
between PPPD and SW in all measured outcome(67)..  
 
SURVIVAL: 
 
 Five-years survival is  favourable in patients with ampullary carcinoma, 
ranging from 34% to 45%, but recent studies have reported as high as 50%. Factors 
universally accepted affecting favorably survival were negative resection margins, 
found in more than 95% of patients, and negative lymph nodes, encountered in 55% 
of patients. It is controversial whether intraoperative blood transfusion and the 
degree of tumor differentiation are important. 
 
 At the analysis of the survival after pancreatoduodenectomy patients with 
duodenal cancer have the longest survival at five years, from 22% to 53% when 
compared with other periampullary tumors. The majority of clinical studies failed to 
demonstrate prognostic significance for demographic factors or tumor grade. 
However, resection with negative resection margins found in more than 90% of 
patients, significantly favoured survival. The influence of positive lymph nodes, 
occurring in 50% to 65% of patients, on survival is controversial. Several authors 
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have demonstrated poor prognosis associated with positive nodal status. Conversely, 
multiple studies have shown that long survival can still be achieved with node 
positive tumors supporting an aggressive approach regarding resection of these 
tumors. 
 
 The 5 year-survival for patients with distal cholangiocarcinoma is 24%. 
Factor associated with prolonged survival are negative lymph nodes, found in only 
30% of patients and well or moderate tumor differentiation occurring in 60% of 
resected tumors. Also, it has been noted that 29% of patients with distal 
cholangiocarcinoma have invasion of extrapancreatic nerve plexus in contrast with 
only 3% in ampullary carcinoma. 
 
 The prognosis of pancreatic adenocarcinoma is one of the most dismal of all 
cancers, approximately 95% of all patients diagnosed with pancreatic cancer will die 
within one year. After potentially curative resection the 5 year survival is 5% to 20% 
making the worst survival of periampullary cancers. Examination of tumor spread 
reveal a high incidence of nodal involvement (75% of patients) and extrapancreatic 
plexus invasion found in 60% of patients. After resection, numerous factors have 
been reported to improve outcome, including tumor size < 2 cm, negative lymph 
nodes, negative resection margins, diploid tumor DNA content, and a lesser degree 
of genetic alteration. The influence of combined-modality chemotherapy and 
radiation therapy is still opened for clinical analysis. 
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 One problem encountered in patients with periampullary cancers after 
pancreaticoduodenectomy is to confirm the site of origin of these tumors. At the 
University of Chicago and at the Mayo Clinic, after reviewing their 3-year survivors 
with presumed ductal carcinoma of the pancreas, investigators found that between 
29% and 39% of tumors could not be confirmed to have arisen in the pancreas. 
Therefore misclassification of tumors is not uncommon and should alert the 
pathologist that the final diagnosis is of great importance on the outcome of survival 
analysis after pancreatoduodenectomy. 
 
 In conclusion, in ampullary and periampullary tumors resection margin 
status, resected lymph node status and degree of tumor differentiation significantly 
influence outcome. Five year survival is most favorable for patients with duodenal 
cancer, followed in declining order by ampullary tumor, distal bile tumor and 
pancreatic adenocarcinoma. 
 
 Survival after surgical resection is related to the extent of local invasion of 
the primary lesion, lymph node involvement, vascular invasion, perineural invasion, 
cellular differentiation, and uninvolved surgical margins. Even a single lymph node 
with evidence of metastatic carcinoma portends a poor outcome with surgery alone. 
Exactly which factors are truly independent remains controversial.  
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PROGNOSTIC FACTORS: 
 
 Several retrospective studies have evaluated the factors affecting survival 
following resection of ampullary carcinomas.Patients with ampullary tumours have a 
better survival than those with adenocarcinomas of pancreas.(67).However ,reported 
series are small and often compiled over several decades.Over this period the 
diagnosis,preoperative staging and treatment of periampullary tumours has evolved 
significantly.The largest report includes 459 patients from 57 centres in Japan 
between 1949 and 1974.(68).The largest single institutional series have been reported 
in the USA (Sloan Kettering ,New York :123 patients,1983-1995(69); John Hopkins 
,Baltimore : 120 patients 1969 -1996(8).and Lahey Clinic ,Boston :112 patients 
(1942-1971)(5).The largest European  series are from the Netherands(Amsterdam :67 
patients ,1984-1992)(10),France  (Rennes:63 patients,1970-1992)(70)Germany 
(Munich : 66 patients,1970-1992)(71)and  the UK (Leicester : 52 patients , 1972- 
1984)(2). 
 
 Nagase et al, from Japan  ,studied the experiences with carcinomas of the 
pancreas, ampulla of Vater, terminal common bile duct, and duodenum found in a 
series of 3,610 patients collected from 57 major Japanese institutions  compiled over 
a 26 year period till 1977. Carcinomas of the ampulla and the terminal common bile 
duct and duodenal regions were the most favourable for resection; usually 
pancreaticoduodenectomy with an overall mortality of 20.8%. As a result of the large 
number of pancreatectomies performed, there was also a large number of 
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postoperative complications, the most frequent being leakage at an anastomotic line. 
Hemorrhage also occurred frequently.The long term survivals following resection for 
these lesions were  poor. The best mean survival time was 22.7 months for 
carcinoma of the ampulla of Vater. Patients having resections for carcinoma of the 
head of the pancreas had a mean survival time of 12.3 months. At 5 years there were 
few survivors and most of them were patients who had undergone resections for 
carcinoma of the ampulla of Vater.(68). 
 
 Howe et al , from MSKCC , analysed  patients with  adenocarcinoma of the 
ampulla of Vater  to identify clinicopathologic factors that have an impact on patient 
survival,,Factors significantly correlated with improved survival were resection (p < 
0.01), and in resected tumors, negative nodes (p = 0.04) and margins (p = 0.02) 
independently predicted for improved survival. In periampullary tumors, the highest 
rates of resection and overall survival (median, 43.6 months) were found in 
ampullary carcinoma (69) 
 
 Talamini et al found , among patients with periampullary adenocarcinoma 
,treated by pancreaticoduodenectomy, those with duodenal adenocarcinoma are most 
likely to survive long term. Five-year survival is less likely for patients with 
ampullary, distal bile duct, and pancreatic primaries, in declining order. Resection 
margin status, resected lymph node status,and degree of tumor differentiation also 
significantly influence long-term outcome. Particularly for patients with pancreatic 
adenocarcinoma, 5-year survival is not equated with cure, because many patients die 
of recurrent disease >5 years after resection.(8) Operative blood transfusions 
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conferred a poorer 5-year survival rate on univariate analysis but not on multivariate 
analysis. 
 
 Allema et al,  from Netherlands found that ,the overall 5-year survival was 
50%. Survival was significantly influenced by the involvement of resection margins. 
After resection with involved margins 5-year survival was 15% and 60% after 
resection with free margins (p < 0.001). Tumor size, lymph node involvement, and 
differentiation grade had limited and not significant influence on survival. (9) 
 
 el-Ghazzawy et al reviewed experiences in the US Department of Veterans 
Affairs hospitals from 1987-1991, during which time 123 patients were diagnosed 
with ampullary cancer. In the group that underwent surgical resection, perineural 
invasion, microlymphatic invasion, vascular invasion, or tumor differentiation did 
not independently influence survival when the tumors were controlled for stage (72) 
 
 Yamaguchi et al compared 18 variables among 8 long-term survivors and 12 
short-term survivors with ampullary cancer and found that only perineural invasion 
and histologic grade were significant.(73) 
 
 Akwari et al noted that factors associated with favourable survival were 
histological differentiation (Broders grade 1,2),absence of nodal metastasis and  
papillary histologic chracteristics(74). 
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 Recent reviews of single-institution surgical experiences of ampullary cancer 
have focused on the identification of histopathologic features associated with 
prognosis and survival. Retrospective review, small patient numbers, and long 
periods of enrollment limit what can be learned from these studies. However, 
common themes emerge from these published clinicopathologic analyses. 
 
 Lowe et al, from U.S., found , on log rank testing, > or = T3 (24 vs 65 mos, P 
< 0.01), N1 (25 vs 61 mos, P < 0.01), poor differentiation (24 vs 44 mos, P = 0.01), 
pancreaticobiliary subtype (23 vs 44 mos, P = 0.01), and PNI (23 vs 44 mos, P < 
0.01) were significant for worse survival. By multivariate analysis, N1 disease 
(hazard ratio [HR] 4.50, 95% confidence interval [CI] 1.16-17.40) and PNI (HR 
4.62, CI 1.11-19.21) maintained associations with worse survival, whereas 
histological subtype did not. N1 disease and presence of PNI demonstrated 
independent associations with worse survival. Given high percentage of mixed 
histology, PNI may be more informative than the subtype in predicting outcome for 
patients with AmpCA.(75) 
 
 In a recent review of 450 cases of surgical resection of ampullary adenoma or 
adenocarcinoma at Johns Hopkins, Winter et al, found that 96.7% of the patients had 
undergone pancreaticoduodenectomy rather than local excision. These researchers 
concluded that pancreaticoduodenectomy should be the preferred approach for most 
ampullary neoplasms that require surgical resection, given that nearly 30% of the 
JohnsHopkins patients with T1 disease had lymph node metastases. Factors 
associated with the presence of lymph node metastasis included tumor size >1 cm  
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(odds ratio [OR] 2.1), poor histologic grade (OR 4.8), perineural invasion (OR 3.0), 
microscopic vessel invasion (OR 6.6), and depth of invasion > pT1 (OR 4.3; all P < 
0.05). Specifically, risk of lymph node metastasis increased with T stage (T1, 28.0%; 
T2, 50.9%; T3, 71.7%; T4, 77.3%; P< 0.001)(76).. 
 
 In a retrospective review of 46 consecutive cases of ampullary carcinoma, 
multivariate analysis by Su et al, showed perineural invasion to be a significant 
independent predictor of poor prognosis (P = 0.024). On univariate analysis, other 
significant predictors of poor prognosis were T3 and T4 tumors (i.e., pancreatic 
parenchymal invasion) (P < 0.001) and lymph node metastasis (P = 0.01)(77). 
 
 Uchida et al found that patients with preoperative jaundice had poorer 
survival than those without jaundice (5-year survival 57.2% vs. 100%, P < 0.01)(78).  
 Bettschart et al ,from U.K.,analysed ,over an 11-year period, 561 patients  
treated for periampullary tumours, 88 of whom had a histologically proven 
ampullary neoplasm. Prospectively gathered data were analysed to assess predictors 
of survival. On univariate analysis, age less than 70 years (P = 0·015) and a bilirubin 
level of 75 µmol/l or less (P = 0·012) favoured long-term survival. Among 70 
patients who underwent cancer resection, factors associated with significantly worse 
long-term survival on univariate analysis included poorly differentiated tumour (P < 
0·001), positive nodes (P < 0·001), perineural invasion (P = 0·001) and invasion of 
the pancreas (P = 0·018). Multivariate analysis identified positive nodes and bilirubin 
concentration as independent predictors of survival.(79) 
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 Chan et al,in a retrospective study,analysed the outcome and potential 
prognostic factors of 60 patients with surgically resected periampullary tumors   
According to the Cox analysis ,ampullary  tumours ,absence of neural invasion and 
use of adjuvant chemotherapy were significant factors for longer survival of patients 
with ampullary tumours.(6) 
 
 Qiao et al,in a study from China, found that the  factors that significantly 
influenced survival were lymph node status (P < 0.001), depth of tumor infiltration 
(P = 0.029), and TNM stage (P < 0.001) on univariate analysis. On multivariate 
analysis, both depth of infiltration and lymph node status were the independent 
determinants of survival after resection (P = 0.003, P = 0.005, respectively (80). 
 
 Berberat et al , from Germany, found that five-year survival was 50.5%, 
29.9% and 24.5% for AmpCA, CholCA and DuoCA, respectively. Multivariate 
analysis identified low bilirubin levels(<100 micromol/l), R0 resections and absence 
of surgical complications to be strong independent predictors of survival (p<0.05). In 
AmpCA low tumor stages are also an independent predictor of long-term survival 
(p<0.01). For T1/T2 AmpCA the 5-year survival rate was 61%, whereas none of the 
patients with a T3/T4 tumor survived 5 years(81). 
 
 Yeo et al in a single-institution experience retrospectively reviewed the 
outcomes in a group of patients treated 5 or more years ago by 
pancreaticoduodenectomy for periampullary adenocarcinoma survivors. The tumor-
specific 5-year actual survival rates were pancreatic 15%, ampullary 39%, distal bile 
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duct 27%, and duodenal 59%. When compared with patients who did not survive 5 
years, the 5-year survivors had a significantly higher percentage of well-
differentiated tumors (14% vs. 4%; p = 0.02) and higher incidences of negative 
resection margins (98% vs. 73%, p < 0.0001) and negative nodal status (62% vs. 
31%, p < 0.0001). The tumor-specific 10-year actuarial survival rates were 
pancreatic 5%, ampullary 25%, distal bile duct 21%, and duodenal 59%. They 
concluded that among patients with periampullary adenocarcinoma treated by 
pancreaticoduodenectomy, those with duodenal adenocarcinoma are most likely to 
survive long term. Five-year survival is less likely for patients with ampullary, distal 
bile duct, and pancreatic primaries, in declining order. Resection margin status, 
resected lymph node status, and degree of tumor differentiation also significantly 
influence long-term outcome. (82) 
 
 Jarufe et al from UK,analysed the post-operative outcome, and determining 
risk factors for survival after pancreaticoduodenectomy for periampullary and 
pancreatic head carcinoma. : Median actuarial survival for carcinoma of the 
pancreatic head, ampulla and distal bile duct were 13.4, 35.5 and 16 months, 
respectively; p < 0.0001. On univariate analysis for the whole series, the age < or 
=60, tumour of the head of the pancreas, lymph node positive, resection margin R1, 
poorly differentiated tumours, and portal vein invasion significantly decreased 
survival. On multivariate analysis, poor tumour differentiation, surgical margin, 
lymph node metastases, and age independently influenced survival. Mortality and 
morbidity were 4.8 and 29.9%, respectively. (83). 
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 Yokoyama et al , evaluated the correlation between jaundice at initial 
presentation and the degree of tumor spread and to determine the prognostic 
significance of jaundice in patients with ampullary carcinoma. Fifty-nine patients 
who had undergone curative resection for ampullary carcinoma were analyzed 
retrospectively. Jaundice was defined as a total bilirubin serum concentration of > or 
= 3 mg/dl.  The survival of patients with jaundice (median survival 48 months; 
cumulative 10-year survival rate 39%) was worse than for patients without jaundice 
(median survival time not available; cumulative 10-year survival rate 86%) (p = 
0.0014)(84). 
 
 Sommerville et al examined the survival differences between ampullary and 
pancreatic head carcinomas after pancreaticoduodenectomy.in a  retrospective review 
of patients with ampullary or pancreatic head adenocarcinoma undergoing curative 
resection during a 6-year period prior to 2000.  Histologically, pancreatic cancer was 
worse, with more lymph node involvement and more positive resection margins and 
vascular and perineural invasions than found in ampullary carcinoma. The median 
disease-free and overall survival rates were significantly better for ampullary cancer 
when compared with pancreatic cancer (17 vs. 9 months [P = 0.001] and 35 vs. 24 
months [P = 0.006], respectively). The actuarial 5-year disease-free and overall 
survival rates were 4.4% and 10.5%, respectively, for pancreatic carcinoma and 
27.9% and 31.8%, respectively, for ampullary carcinoma. Multivariate analysis 
showed that microscopic resection margin involvement (P = 0.02) and involvement 
of over three nodes (P < 0.001) were significant factors affecting the overall survival 
for pancreatic and ampullary carcinomas, respectively. (85). 
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 Sakata et al,  compared the prognostic power of the anatomic location of 
positive nodes with that of the number of positive nodes. Univariate analysis 
revealed that both the location (p<0.0001) and the number (p<0.0001) of positive 
nodes were significant prognostic factors. Multivariate analysis revealed that the 
number of positive nodes was an independent prognostic factor (p=0.007), while the 
location failed to remain as an independent variable. The median survival time was 
59 months with a 5-year survival rate of 48% in patients with 1-3 positive nodes, 
whereas all patients with >or=4 positive nodes died of the disease within 29 months 
of resection (p=0.0001). (86). 
 
 Brown et al,found that the  overall 5-year disease-specific survival was 58% 
for patients with resectable periampullary carcinomas. Five-year survival was 78% 
(21/27) in node-negative patients, 73% (25/34) for T1/T2 patients, and 76% (17/23) 
for well-differentiated tumors compared with 25% for node-positive, 8% for T3/T4, 
and 36% for poorly or moderately differentiated tumors (P<.01). On multivariate 
analysis, only node-negative disease maintained significance (hazard ratio, 5.2; 95% 
confidence interval, 1.2-21.9). In all groups, there were no deaths due to disease after 
3 years of survival was reached. Pancreaticoduodenectomy is curative in 80% of 
patients with node-negative ampullary carcinomas. (87). 
 
 Schmidt et al,in a  retrospective review of a prospectively collected 
databaseof a  total of 516 consecutive patients who underwent PD,analysed  patient 
outcomes and survival factors. Three-year survival was 15% after resection for 
pancreatic cancer, 42% for duodenal cancer, 53% for ampullary cancer, and 62% for 
bile duct cancer. Univariate predictors of long-term survival in patients with 
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periampullary adenocarcinoma included elevated glucose levels, liver function test 
results, abnormal tumor markers, blood loss, transfusion requirement, type of 
operation, and pathologic findings (periampullary adenocarcinoma type, 
differentiation, and margin and node status). Multivariate predictors were serum total 
bilirubin level, blood loss, operation type, diagnosis, and lymph node status. PD can 
be performed safely. Long-term survival in patients with periampullary 
adenocarcinoma can be predicted by preoperative laboratory values, intraoperative 
factors, and pathologic findings(88). 
 
 Van Geenan et al, from The  Netherlands, analysed the independent 
prognostic factors and  survival after standard pancreaticoduodenectomy for 
periampullary carcinomas . In the univariate analysis vein resection, blood 
transfusion of more than four packed red cells, the presence of tumour positive 
resection margins, lymph-node metastases and poor tumour differentiation 
significantly decreased survival. In the multivariate analysis positive resection 
margins, lymph-node metastases, and poor tumour differentiation independently 
influenced survival.(89).  
 
 Monson et al ,found that  patient survival was significantly impaired by 
microscopic lymphatic invasion, regional nodal metastasis, tumor grade, and the 
epithelium of origin. In a multivariate analysis, only microscopic lymphatic invasion 
significantly reduced patient survival. Radical resection for ampullary cancer can be 
performed with a low morbidity and mortality and should remain the procedure of 
choice for ampullary carcinoma.(90). 
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 Sudo et al,found that ,  overall 5-year survival rate was 64% in patients 
undergoing pancreaticoduodenectomy with lymphadenectomy for periampullary 
carcinoma . Univariate analysis revealed that T3 and T4 tumor (i.e., pancreatic 
parenchymal invasion) (P < 0.001), lymph node metastasis (P = 0.01), and perineural 
invasion (P < 0.001) were significant predictors of poor prognosis. Furthermore, 
perineural invasion was found to be a significant independent predictor of poor 
prognosis by multivariate analysis (P = 0.024). Pancreaticoduodenectomy with 
lymphadenectomy for ampullary carcinoma is a safe surgical procedure with an 
acceptable cure rate. The presence of perineural invasion may be useful for 
predicting poor prognosis in patients with ampullary carcinoma who undergo 
potentially curative resection(78). 
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AIMS & OBJECTIVES 
 
 
 
1. To analyse factors influencing survival in a series of patients with  periampullary 
tumours who underwent pancreaticoduodenectomy in  a single tertiary referral 
unit . 
 
2. To examine the results of resection & its impact on clinical outcomes on various 
typesof carcinomas including Ampullary carcinoma,distal  Cholangiocarcinoma 
& Duodenal Carcinoma. 
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MATERIALS AND METHODS 
 
 
 
 
 Pooled data from patients undergoing pancreaticoduodenectomy for 
periampullary carcinoma over a 13 year period from 1995 to 2008 was 
retrospectively evaluated and analysed. 
 
 Included in this study were 69 consecutive cases of nonpancreatic 
periampullary carcinomas ,which during final histological examination proved to be 
ampullary,cholangial or duodenal origin.All patients had adenocarcinoma of 
periampullary region.All patients underwent evaluation and treatment at our institute 
between 1995 to 2008 .  
 
 Patients with benign pathologies,neuroendocrine tumours and carcinoma of 
head of pancreas who underwent pancreaticoduodenectomy were excluded from this 
study . 
 
 All patients underwent thorough clinical examination.Routine 
hemogram,renal function test, liver function test, chest x ray, electrocardiogram were 
done for all patients.  USG Abdomen & pelvis ,CT abdomen & pelvis were done as 
part of staging evaluation. ERCP and stenting were done in selected patients either 
done outside or at our institute.    
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 Patients deemed suitable for resection underwent either a standard 
pancreaticoduodenectomy or pylorus preserving pancreaticoduodenectomy.  
Reconstruction was performed with either pancreaticojejunostomy in earlier cases 
and later on pancreaticogastrostomy, choledochojejunostomy and gastrojejunostomy. 
 
 Surgical morbidity included wound infection,biliary leak,pancreatic leak,re- 
laporotomy and delayed gastric emptying.Pathological assessment included primary 
tumour site,tumour size,histological type,grade ,margin status,nodal involvement, 
pericapsular spread and Lymphovascular invasion. 
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STATISTICAL ANALYSIS 
 
 Statistical analysis was performed using SPSS software.Variables influencing 
overall and disease free survival rates were compared using the Kaplan – Meier 
method using log- rank comparision(102)..Multivariate analysis was performed with 
the cox proportional hazards model,entering variables significant on univariate 
analysis; the results are reported as Odds Ratio with 95 % confidence 
intervals(103).P<0.05 was considered significant.   
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RESULTS 
 
 
 
 
 Between 1995 and 2008,sixty nine patients who underwent curative resection 
for periampullary carcinoma out of  81 patients who underwent 
pancreaticoduodenectomy during the same period were analysed.Out of the 69 
patients , 47(68.1%) had ampullary carcinoma,7(10.1%) had cholangiocarcinoma,10 
(14.4%)had duodenal carcinoma. 
 
 The median followup period was 39 months .The mean patient age was 52 
years.39 (56.5%) were males and 30 (43.4%) were females .Jaundice was present in 
56 patrients(81.1%).50(72.4%) patients had bilirubin < 5 mg%. Standard 
pancreaticoduodenectomy was done in 59 patients(85.5%) & PPPD in 10 patients 
(14.4%).  The average blood loss was 1373 ml.The mean transfusion requirement 
was 2 units.The mean operating time was 6.1 hours. Major complications were 
present including pancreatic leak (13 patients) & biliary leak(5patients) in 18 patients 
(26%).Minor wound infections were present in 22 patients(31.9%).Delayed Gastric 
emptrying in 9 patients(13%).Relaporotomy was done in 4 patients(5.8%) indication 
being post operative haemorrhage..post operative mortality was 5.8%(4 patients).  
 
 The mean size of the tumour was 2 cm.23 patients(33.3%) had node negative 
disease and 46 patients(66.6%) had node positive disease.17.3% were grade I ,55% 
were grade II,27.5% were grade III tumours.    
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The distribution of serum bilirubin is as follows: 
 
 
 
 
 
 
 
 
 
 
 
The distribution of T status is as follows: 
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The distribution of nodal status is as follows: 
 
 
 
 
 
 
 
 
 
 
(node neg- node negative,node pos- node positivity) 
The distribution of Lymphovascular invasion is as follows:        
 
 
 
 
 
 
 
 
 
(LVI-Lymphovascular invasion,LVI  PRE –Lymphovascular invasion present,LVI 
ABS- Lymphovascular invasion absent) 
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TABLE 3 : 
Results of univariate analysis of  perioperative factors are shown in TABLE 3. 
 
Variable  No. of patients P value 
Sex                               Male  
                                      Female 
Age          <50 
                >50   
Blood transfusion         yes 
                                    No 
Preop bilirubin    0-4.99 
                           5-9.99 
                           >10 
Preop albumin    <3 
                           >3 
Preop Hb            < 10 
                           >10  
Preop Jaundice     yes  
                            No 
Preop biliary drainage   Yes 
                                       No  
Complication      yes 
                                       No 
Adjuvant chemotheraphy  yes 
                          No 
Blood loss           <1000ml
                           >1000ml  
39(56.5%) 
30(43.4%) 
26(37.7 %) 
43(62.3%) 
55(79.7%) 
14(20.2%) 
50(72.4%) 
7(10.1%) 
12(17.3%) 
11(15.9%) 
58(84.05%) 
10(14.4%) 
59(85.5%) 
56(81.1%) 
13(18.8%) 
36(52.17%) 
33(47.82%) 
34(49.27%) 
35(50.72%) 
5(7.2%) 
63(91.30%) 
35(50.72%) 
34(49.27%) 
0.36 
 
0.75 
 
0.43 
 
0.0153 
 
 
0.34 
 
0.29 
 
0.5 
 
0.15 
 
0.46 
 
 
0.79 
 
0.28 
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TABLE 4: 
The univariate analysis of  pathological factors for resected periampullary 
carcinomas are shown in TABLE 4. 
 
Variable No. of patients P value 
Size of the tumour    < 2 cm  
                                 >2 cm 
 T status                   T1 
                               T2 
                               T3  
Nodal status          Positive 
                             Negative   
Grade                   I 
                            II         
                            III   
LVI                    yes 
                          No  
Perinodal spread                      yes 
                         No  
Site of tumour-                        ampulla 
                         Duodenum 
                        Distalbileduct
No. of nodes positive          0 
                       1 
                       2 or more 
Margin                    Positive 
                     Negative 
Perineural spread        Present 
                   absent  
38(55.07%) 
31(44.92%) 
6(8.6%) 
38(55.02%) 
25(36.23%) 
23(33.33%) 
46(66.66%) 
12(17.39%) 
38(55.07%) 
19(27.53%) 
9(13.04%) 
60(86.95%) 
10(14.4%) 
59(85.5%) 
52(75.36%) 
10(14.4%) 
 7(10.1%) 
46(66.66%) 
8(11.5%) 
15(21.7%) 
3(4.3%) 
66(95.65%) 
(2.8%) 
67(97.1%) 
1.0 
 
0.01 
 
 
0.0052 
 
0.82 
 
 
0.02 
 
0.17 
 
0.62 
 
 
0.02 
 
 
0.69 
 
0.61 
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 By univariate analysis the following perioperative factors & pathological 
factors were analysed.The perioperative factors include age,sex,blood loss,blood 
transfusions,preoperative bilirubin (divided in to three groups – Group 1- 0.5 
mg/dl,Group 2 – 5.1-10 mg/dl.Group 3 – above 10 mg/dl.),preoperative 
hemoglobin,preoperative albumin and surgical complications.The pathological 
factors include tumour size,T status ,stage of the disease,nodal status,number of 
positive nodes,grade of the tumour,Lymphovascular invasion,pericapsular spread. 
 
 On univariate analysis preoperative bilirubin(high bilirubin range),T status , 
node positivity and Lymphovascular invasion were associated with a worse overall 
survival.On multivariate analysis preoperative bilirubin , Node  Positive disease 
,Lymphovascular invasion were associated with poorer overall survival. 
 
TABLE 5: 
Multivariate analysis of overall survival in resected periampullary carcinoma 
Variable  Hazard ratio(95% confidence interval) 
P – 
value 
Preop 
Bilirubin 
Group 1(0-5 mg/dl) 
Group 2(5.1-10mg/dl) 
Group 3(>10 mg/dl) 
1 
0.3(0.5-1.2) 
2.9(1.2-7.1) 
0.02 
Nodal status Node positive 
Node negative 
1 
3.0(1.2-7.5) 
0.02 
LVI Present 
Absent 
1 
0.3(0.1-6.9) 
0.04 
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 Disease free Survival were 48.2%,76.5%,64.8% for ampullary,duodenal and 
cholangiocarcinomas.There was no statistical difference on comparing the three 
sites.20(28.9%) patients developed  recurrence including 18 (26%) patients with 
distant recurrence.The 5  Year Overall  survival for all patients was 47.8 % . 
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DISCUSSION 
 
 
 
 
 Previous reports suggest that patients with ampullary tumours have better 
survival than those with adenocarcinoma of the head of the pancreas(8).However 
,reported series are small and often compiled over several decades.Over this period 
the diagnosis preoperative staging and treatment of periampullary tumours has 
evolved significantly.The present series  report patients with periampullary tumour 
represents another large series from a single institution ,with 69 patients managed 
between 1995 and 2008.The 5 year survival rate after resection of periampullary 
carcinoma is 47.8%.The present 5 year survival rate is similar to  most other large 
series in which the actuarial  survival ranges from 34 to 45 %(8,10,91,92).Some 
reports presented even higher 5 year survival rates between 55 %and 
61%(2,60,93,94). There are wide variations in median survival and the percentage of 
5-year survivors, with the lowest survival figures generally coming from series 
dating back many decades. Nakase et al.(68) reported a 5-year survival rate of only 
6%, which may have been negatively influenced by their data being derived from 57 
different institutions. The operative mortality in this study was 16%, and high 
operative mortality appears to be a factor in the diminished survival reported in other 
series.Most of these studies include data from the 1940s to 1970s and therefore have 
not benefited from the improvements made in patient care over the past 2 decades.  
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 During the current series there were no changes in the surgical procedure 
with regard to the extent of the resection or the lymph node resection, except for the 
shift towards pancreatico gastrostomy.Both classical pancreaticoduodenectomy and 
Pylorus preserving Pancreaticoduodenectomy has been performed.Both types of 
resection result in a comparable survival (39). 
 
 In this study,age ,sex,jaundice,blood loss,no. of blood 
transfusions,preoperative bilirubin ranges ,preoperative hemoglobin,preoperative 
albumin,preoperative biliary drainage , complications of surgery, adjuvant 
chemotheraphy were the perioperative factors taken for univariate analysis.Tumour 
size,T status,nodal status,grade,Lymphovascular invasion ,perinodal spread, margin 
status and perineural invasion were the tumour factors taken for univariate analysis. 
Preoperative bilirubin,T status,node positivity and Lymphovascular invasion  
predicted for improved survival by univariate analysis.Preoperative bilirubin ,node 
positivity and Lymphovascular invasion  were independently correlated with survival 
in resected patients by multivariate analysis. 
 
 Several studies confirm the significant association of nodal 
metastases(63,90,93) tumor grade(2,66,59) and margin status(60)with patient 
survival. Others have found that tumorstage(2,60-62), tumor size(63) perineural 
invasion (25,64), lymphatic invasion,(2,25) venous 
invasion,(25)adjuvantchemotherapy(64) and blood transfusion(8) were significantly 
correlated with survival. Although a report from Johns Hopkins found blood 
transfusion, lymph node status, and tumor differentiation to be significant by 
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univariate analysis, none of these factors reached the threshold of significance by 
multivariate analysis(8).  
 
 In other studies that performed multivariate analysis , the only significant 
factor by multivariate analysis by Allema et al. was the margin of resection,(10) and 
by Monson et al(9) (after exclusion of nonampullary cases) was lymphatic invasion. 
In a smaller series of 28 resected patients,Neoptolemus et al.(2) found both tumor 
grade and tumor stage(where stage IV was defined as lymph node involvement) to be 
significant by multivariate analysis.For resected ampullary adenocarcinoma, several 
factors have been variably associated with survival(8,9,91,97) including tumor size, 
histologic differentiation, lymph node status,resection margin status, and 
perioperative blood transfusion.   
 
 A recent study interpreted high bilirubin levels as a sign of advanced stage by 
showing correlations with tumour related variables such as lymph node 
metastasis,pancreas and vessel invasion.(84).Bettschart et al, found that  age and 
bilirubin concentration as two tumour independent factors predictive of survival in 
univariate analysis ,whereas a low bilirubin concentration favoured survival in 
multivariate analysis of the whole group(79).Few multivariate analysis have been 
performed to define non tumour related prognostic factors(8,69).Neoptolemos et al 
found no impact of bilirubin concentration ,but their series included only 22 patients 
undergoing Whipple’s resection.(2).Berberat et al showed that high bilirubin 
negatively influences long term survival in non pancreatic periampullary 
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carcinomas.(81). The present study shows low bilirubin concentration favouring 
survival in both univariate and multivariate analysis. 
 
 Bettschart et al found that ,there was no significant difference in survival for 
patients with T 1 versus T 2 tumours.,wheareas T 3 tumours had a significant impact 
on survival.Poor differentiation was shown to affect survival in univariate analysis 
only(79).Berberat et al showed that extension of    ampullary carcinoma into the 
pancreas (T3and T4) as a strong tumour related independent factor for survival .On 
univariate analysis low stage (T1,T2) and also absence of microscopic vessel 
invasion were associated with better survival.But multivariate analysis showed only 
low T status as an independent indicator of better survival in ampullary 
carcinomas.(81).Stiff et al showed that age,gender ,shape,degree of differentiation 
,presence of vascular invasion were all found not significant.(7).The present study 
showed significant impact on survival  of T 3 tumours compared to T1,T2 tumours 
on univariate analysis but not in multivariate analysis.Stage of the disease was found 
to be significant on univariate analysis but on multivariate analysis. Gender,tumour 
size, grade and pericapsular spread were not found to be significant factors for 
survival. 
 
 The incidence of nodal metastases ranges from 29% to 52%, with a mean of 
40%(10,57).The presence of lymph node metastases proved to be a strong prognostic 
factor for survival in this study as in this study by Van Geenen et al(89).In ampullary 
carcinoma , the overall nodal status rather than the number of lymph nodes involved 
is the important factor associated with survival as in our study(87).However others 
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have shown that the number of nodes involved is of greater significance as a 
prognostic factor in addition to the overall nodal status  when four or more nodes 
involved(87,95).In a series by Sommerville et al ,all patients with four or more nodes 
involved died of their disease within 29 months,with a median survival of 14 
months(85).In the current series though the presence of two or more nodes was 
statistically significant by univariate analysis(p=0.02) ,it did not reach significance in 
multivariate analysis.The presence of positive lymph  nodes was significant by 
univariate and multivariate analysis. 
 
 There is little agreement between published series as to which of these factors 
are the most important ,although lymph node positivity,tumour stage and perineural 
invasion are the factors most frequently cited.Stiff et al found that T stage ,N stage 
and the presence of perineural invasion to be significantly associated with a poorer 
outcome whereas age,shape ,degree of differentiation ,presence of vascular invasion, 
and blood transfusion requirements were not significant.(7).Bettschart et al showed 
that the most important factors for predicting survival were tumour related, such as 
pancreatic invasion,differentiation,perineural invasion and lymph node 
involvement.(79).The present study showed Lymphovascular invasion as a factor 
predicting survival in both univariate and multivariate analysis . 
 
 Several studies also reported tumour independent factors to be predictive of 
long term survival in multivariate analysis such as young age and absence of 
intraoperative transfusion.(79,83).Berberat et al ,showed surgical complications to be 
a strong indicator of shorter survival indicating safe surgical technique to be crucial 
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not only for the short term but also for the long term outcome of the 
patients.(81).Howard et al found , on multivariate analysis ,that tumor size,tumor 
grade ,post operative complications and resection margins were the most important 
co variables affecting survival,but that the absence of postoperative complications 
provided the most benefit in reducing the risk of dying from the disease(50).In the 
present study on analyzing the perioperative factors for impact on survival ,such as 
age,sex,blood transfusions,blood loss,preoperative bilirubin,preoperative 
hemoglobin,preoperative albumin and surgical complications,only preoperative 
bilirubin was found to be significant. In the present study,Age ,blood transfusions 
and surgical complications were not found to be significant factors as in other 
studies.    
 
 Recent studies in distal cholangiocarcinoma revealed much better survival 
with 27-41% 5 year survival  rates (53,100,101).The small group of duodenal 
adenocarcinomas represent a rarity under gastrointestinal tumours.The few series 
reported in literature show a wide variation of 5 year survival rates from 20-
75%(53,78,88).Berberat et al showed a 5 year survival of 50.5 %,29.9% and 24.5 % 
for ampullary carcinoma ,cholangiocarcinoma and duodenal carcinoma.The present 
study showed a 5 year survival rate of 48.2%,64.8%and 76.5% for ampullary, 
cholangiocarcinoma and duodenal carcinomas.  If one looks at survival after 
resection, patients with duodenal cancer survivedlonger than those with ampullary 
cancer. One explanation for the observed patterns of survival in these periampullary 
tumors is that there are fundamental differences in tumor biology between these 
neoplasms.Whipple  suggested that ampullary tumors were "better differentiated, of 
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the adenomatous type, slower to invade the lymphatics and blood vessels(46).  
Survival of patients with ampullary tumors generally followed closely behind those 
with duodenal tumors, whereas survival of patients with bile duct tumors generally 
fell between those with ampullary and pancreatic cancers. Perhaps periampullary 
tumors represent a biologic spectrum of malignancies, where intestinal-type tumors 
(like duodenal cancer) comprise the biologically more favorable end of the spectrum 
and pancreaticobiliary tumors the other.In the present study, patients with duodenal 
adenocarcinoma had a better survival followed by cholangiocarcinoma and 
ampullary carcinoma.  
 
 The morbidity associated with pancreaticoduodenectomy has decreased in 
recent years but remains substantial(64),ranging from 18 to 68 percent.(95).The 
major morbidity following pancreaticoduodenectomy in this study is 26 %. Post 
operative mortality was 5.8%.(4 patients). 
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CONCLUSION 
 
 
 
 
 Preoperative bilirubin , nodal involvement and Lymphovascular invasion are 
important predictors of survival in those who undergo resection of  non pancreatic 
periampullary carcinoma.Ampullary tumours have a good prognosis, as they are 
often resectable .The acceptable morbidity rate among resected patients , support an 
aggressive surgical approach to the management of ampullary tumours.                
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